Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion type Assertion NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_head.
- NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion description "[Moreover, of the patients with advanced urothelial carcinoma who underwent complete resection disease-free survival of those with an elevated CD44v8-10- to -standard CD44 ratio was significantly lower than that of patients with a normal ratio.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_provenance.
- NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion evidence source_evidence_literature NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_provenance.
- NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion SIO_000772 11832714 NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_provenance.
- NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion wasDerivedFrom befree-2016 NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_provenance.
- NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_assertion wasGeneratedBy ECO_0000203 NP344288.RAgCevLx0Hgz1fLHe5MxLAjZsCqblnp-yO_H9OPR_b-Zg130_provenance.